Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

olanzapine

OLANZapine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
ZyPREXA Relprevv POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR 210 mg, 300 mg, 405 mg      
ZyPREXA POWDER FOR INJECTION, INTRAMUSCULAR 10 mg      
ZyPREXA Zydis TABLET, DISINTEGRATING, ORAL 5 mg, 10 mg      
ZyPREXA TABLET, ORAL 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg      


Comments:

ZyPREXA tablet and ODT medication guide

ZyPREXA Relprevv medication guide


ZyPREXA Relprevv is non-formulary, not stocked. Contact the physician for an alternative agent for inpatient treatment or defer the injection to the outpatient setting.


Oral OLANZapine protocol available for adult inpatients for highly emetogenic chemotherapy prophylaxis. 


Reviewed: February 23, 2005 (Zyprexa IM) and January 25, 2011 (ZyPREXA Relprevv), October 22, 2019


REMS (ZyPREXA Relprevv): View FDA REMS Info


Last updated: Oct. 28, 2019







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.